Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 3.047
Filter
1.
Bull Exp Biol Med ; 171(3): 342-346, 2021 Jul.
Article in English | MEDLINE | ID: mdl-34297288

ABSTRACT

Combined treatment of murine leukemia P388 with doxorubicin and platinum(IV)-nitroxyl complex ВС118 administered in low doses improved efficiency of treatment (cure of 83% of animals) without increasing toxicity.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/pharmacology , Cytostatic Agents/pharmacology , Doxorubicin/pharmacology , Leukemia P388/drug therapy , Organoplatinum Compounds/pharmacology , Animals , Drug Administration Schedule , Leukemia P388/mortality , Leukemia P388/pathology , Longevity/drug effects , Mice , Mice, Inbred DBA , Survival Analysis
2.
Mar Drugs ; 19(2)2021 Jan 31.
Article in English | MEDLINE | ID: mdl-33572527

ABSTRACT

A number of bioactive marine natural products have been isolated so far, but it is still difficult to disclose their modes of action. In this study, we prepared fluorescently labeled chemical probes from the cytotoxic marine cyclic peptides kapakahines A (1) and F (2) to visualize their localization as the first step of the study of their modes of action. We used fluorescent dyes 3a or 3a/b (a 1:1 mixture of 3a and 3b) whose terminal N-hydroxysuccinimide (NHS) group can react with the free amino groups of kapakahines. The fluorescently labeled kapakahine A (Kap A-5-FL, 5a) stained P388 murine leukemia cells and HeLa human cervical cancer cells, while cells treated with fluorescently labeled kapakahine F (Kap F-5-FL, 6a) only weakly stained them. Further analysis of the confocal images of the stained cells with higher magnification (×100) indicated the localization of Kap A-5-FL (5a) in the cells. In this paper, we report the small-scale preparation and a new delivery method of fluorescent probes, as well as the application of these procedures to cell staining.


Subject(s)
Fluorescent Dyes/pharmacology , Peptides, Cyclic/pharmacology , Animals , HeLa Cells , Humans , Leukemia P388 , Mice
3.
Bull Exp Biol Med ; 169(6): 778-782, 2020 Oct.
Article in English | MEDLINE | ID: mdl-33123920

ABSTRACT

Preclinical study of therapeutic properties of an innovative drug Doxorubicin-NPh (doxorubicin in the form of ultrafine suspension of phospholipid liposomes) in comparison with free doxorubicin (Doxorubicin-Teva) and protected doxorubicin (Caelyx) was performed on transplanted murine tumor models. All these drugs were efficient in Ca755 breast carcinoma model (tumor growth inhibition ≈100%, increase in lifespan 90.6-114.3%). In P388 lymphocytic leukemia and LLC lung carcinoma, advantages of the protected doxorubicin by the benefit/risk ratio (width of therapeutic interval) were demonstrated: Caelyx>Doxorubicin-NPh>Doxorubicin-Teva. Doxorubicin-NPh and Caelyx exhibited similar therapeutic activity in the LLC model, especially when administered 3 times with 3-day intervals; for Doxorubicin-Teva, the optimal interval between the injections was 7 days.


Subject(s)
Antibiotics, Antineoplastic/pharmacology , Carcinoma, Lewis Lung/drug therapy , Doxorubicin/analogs & derivatives , Doxorubicin/pharmacology , Leukemia P388/drug therapy , Mammary Neoplasms, Experimental/drug therapy , Allografts , Animals , Antibiotics, Antineoplastic/pharmacokinetics , Carcinoma, Lewis Lung/pathology , Doxorubicin/pharmacokinetics , Drug Evaluation, Preclinical , Female , Humans , Leukemia P388/pathology , Liposomes/chemistry , Mammary Neoplasms, Experimental/pathology , Mice , Mice, Inbred C57BL , Mice, Inbred DBA , Phospholipids/chemistry , Polyethylene Glycols/pharmacokinetics , Polyethylene Glycols/pharmacology , Tumor Burden/drug effects
4.
Anticancer Drugs ; 31(6): 617-622, 2020 07.
Article in English | MEDLINE | ID: mdl-32044797

ABSTRACT

Cyclophosphamide is an inert prodrug converted into 4-hydroxycyclophosphamide (OHCP) by hepatic hydroxylation. OHCP is in equilibrium with its tautomeric aldophosphamide (ALDO). From ALDO, the cytotoxic active metabolites are formed enzymatically by phosphodiesterases; these are the alkylating metabolite phosphoramide mustard (PAM) and the proapoptotic aldehyde 3-hydroxypropanal (HPA). PAM damages the DNA by alkylation; HPA amplifies the thereby induced apoptosis. The generally accepted view that acrolein, which is believed to be formed in the formation of PAM by ß-elimination from ALDO would be mainly responsible for the toxicity of cyclophosphamide, has to be revised because no acrolein is formed in the systemic circulation of patients after cyclophosphamide administration. It is shown that not acrolein, but OHCP itself is the true toxic metabolite of cyclophosphamide. Toxicity tests with OHCP and PAM were carried out, which demonstrated that OHCP unfolds its toxicity, not as a carrier of PAM but is toxic itself by reacting with nucleophilic groups of macromolecules, for example, thiol groups of membrane proteins. Further experiments demonstrate that the toxicity of oxazaphosphorine cytostatics may be drastically reduced if the formation of the pharmacologically active metabolite ALDO bypasses the formation of OHCP. Toxicity experiments in mice with S-ethanol-cyclophosphamide (SECP) that hydrolyzes to OHCP show that SECP is as toxic as OHCP, whereas the thiazolidine of ALDO, which hydrolyzes to ALDO bypassing OHCP is 7-9 times less toxic without loss of antitumor activity.


Subject(s)
Antineoplastic Agents, Alkylating/toxicity , Cell Proliferation/drug effects , Cyclophosphamide/analogs & derivatives , Cyclophosphamide/toxicity , Leukemia P388/pathology , Phosphoramide Mustards/toxicity , Animals , Antineoplastic Agents, Alkylating/chemistry , Cyclophosphamide/chemistry , Female , Leukemia P388/drug therapy , Male , Mice , Phosphoramide Mustards/chemistry , Toxicity Tests
5.
J Antibiot (Tokyo) ; 73(1): 60-65, 2020 01.
Article in English | MEDLINE | ID: mdl-31481763

ABSTRACT

A norditerpenoid k4610422 (1), an inhibitor of testosterone-5α-reductase originally discovered from a mesophilic rare actinomycete of the genus Streptosporangium, was isolated from the culture extract of a thermophilic actinomycete Actinomadura sp. The complete 1H and 13C NMR assignment and absolute configuration of 1 were addressed by spectroscopic measurements including NOESY and CD spectra coupled with ECD calculation, which allowed to establish the (5 R,9 S,10 R,13 S)-configuration. Compound 1 was moderately cytotoxic against P388 murine leukemia cells with IC50 30 µM.


Subject(s)
3-Oxo-5-alpha-Steroid 4-Dehydrogenase/drug effects , Actinomycetales/chemistry , Androgen Antagonists/chemistry , Androgen Antagonists/pharmacology , Animals , Anti-Bacterial Agents/isolation & purification , Anti-Bacterial Agents/pharmacology , Bacteria/drug effects , Circular Dichroism , Diterpenes , Fermentation , Leukemia P388/drug therapy , Magnetic Resonance Spectroscopy , Microbial Sensitivity Tests
6.
Bull Exp Biol Med ; 167(3): 339-342, 2019 Jul.
Article in English | MEDLINE | ID: mdl-31346869

ABSTRACT

Activities of superoxide dismutase and catalase and content of reduced glutathione in cells of drug-resistant murine leukemia P388 strains were studied without or after administration of antitumor compounds. In the absence of chemotherapeutic agents, no significant differences in activities of the studied enzymes in cells of the initial strain and strains resistant to cyclophosphamide, cisplatin, and rubomycin were observed. Compounds to which resistance was developed did not significantly affect activity of enzymes in cells of drug-resistant strains, while the use of compounds that were not resistance inductors was accompanied by a significant decrease in enzyme activity in cells resistant to cisplatin and rubomycin. In cells of strains resistant to cisplatin and cyclophosphamide, the content of reduced glutathione significantly differed from that in the initial strain. In addition, the concentration of reduced glutathione in cells of cyclophosphamide-resistant strain considerably decreased upon addition of the drug producing a therapeutic effect. Our findings suggest that the mechanism of resistance of in vivo derived cyclophosphamide resistant cell strain is related to increased level of reduced glutathione and activity of its metabolism.


Subject(s)
Antineoplastic Agents/pharmacology , Catalase/metabolism , Drug Resistance, Neoplasm/physiology , Glutathione/analysis , Leukemia P388/drug therapy , Superoxide Dismutase/metabolism , Animals , Antioxidants/metabolism , Cell Line, Tumor , Cisplatin/pharmacology , Cyclophosphamide/pharmacology , Daunorubicin/pharmacology , Doxorubicin/pharmacology , Mice , Mice, Inbred DBA , Reactive Oxygen Species/metabolism
7.
J Antibiot (Tokyo) ; 72(8): 634-639, 2019 08.
Article in English | MEDLINE | ID: mdl-31118481

ABSTRACT

A new catecholate-containing siderophore, labrenzbactin (1), was isolated from the fermentation broth of a coral-associated bacterium Labrenzia sp. The structure and absolute configuration of 1 was determined by spectroscopic methods and Marfey's analysis. Overall, 1 showed antimicrobial activity against Ralstonia solanacearum SUPP1541 and Micrococcus luteus ATCC9341 with MIC values of 25 and 50 µg ml-1, respectively, and cytotoxicity against P388 murine leukemia cells with an IC50 of 13 µM.


Subject(s)
Alphaproteobacteria/chemistry , Anthozoa/microbiology , Anti-Bacterial Agents/isolation & purification , Catechols/isolation & purification , Oxazoles/isolation & purification , Siderophores/isolation & purification , Alphaproteobacteria/isolation & purification , Animals , Anti-Bacterial Agents/pharmacology , Antibiotics, Antineoplastic/isolation & purification , Antibiotics, Antineoplastic/pharmacology , Catechols/pharmacology , Drug Screening Assays, Antitumor , Fermentation , Leukemia P388/drug therapy , Mice , Microbial Sensitivity Tests , Micrococcus luteus/drug effects , Molecular Structure , Oxazoles/pharmacology , Ralstonia/drug effects , Siderophores/pharmacology
8.
Bull Exp Biol Med ; 166(4): 456-460, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30810868

ABSTRACT

We performed an in vivo comparative study of activity of three substances of the nitrosourea group produced in Russia. All substances demonstrated high antitumor activity against various solid and leukemic tumors. Aranosa significantly enhanced life duration in mice with leukemia (by 65-194%) and inhibited the growth of solid tumors (by 49-99.6%). Lisomustine and ormustine showed higher activity than aranose. Single administration of lisomustine increased life span of mice (by 22-114%) and resulted in cure of all animals in four models: lymphoblastic leukemia L-1210, lymphocytic leukemia P-388, Lewis lung carcinoma, and cervical cancer RShM-5. After ormustine treatment, full recovery was observed only in groups with lymphocytic leukemia P-388 and cervical cancer RShM-5. These findings attest to higher activity of lisomustine in the studied models.


Subject(s)
Antineoplastic Agents/therapeutic use , Nitrosourea Compounds/therapeutic use , Animals , Female , Leukemia L1210/drug therapy , Leukemia P388/drug therapy , Male , Mice , Neoplasms, Experimental/drug therapy , Russia , Treatment Outcome , Uterine Cervical Neoplasms/drug therapy
9.
J Nat Prod ; 81(9): 2106-2110, 2018 09 28.
Article in English | MEDLINE | ID: mdl-30130105

ABSTRACT

The production of two new heterocyclic peptide isomers, catenulobactins A (1) and B (2), in cultures of Catenuloplanes sp. RD067331 was significantly increased when it was cocultured with a mycolic acid-containing bacterium. The planar structures and absolute configurations of the catenulobactins were determined based on NMR/MS and chiral-phase GC-MS analyses. Catenulobactin B (2) displayed Fe(III)-chelating activity and moderate cytotoxicity against P388 murine leukemia cells.


Subject(s)
Micromonosporaceae/metabolism , Mycolic Acids/analysis , Oxazoles/metabolism , Peptides/metabolism , Animals , Chelating Agents/chemistry , Chelating Agents/isolation & purification , Chelating Agents/metabolism , Chelating Agents/pharmacology , Leukemia P388/drug therapy , Leukemia P388/pathology , Magnetic Resonance Spectroscopy , Mice , Oxazoles/chemistry , Oxazoles/isolation & purification , Oxazoles/pharmacology , Peptides/chemistry , Peptides/isolation & purification , Peptides/pharmacology
10.
J Antibiot (Tokyo) ; 71(7): 653-657, 2018 07.
Article in English | MEDLINE | ID: mdl-29540776

ABSTRACT

New polycyclic tetramate macrolactams, Umezawamides A (1) and B (2) were isolated from a combined-culture of Umezawaea sp. RD066910 and mycolic-acid containing bacterium Tsukamurella pulmonis TP-B0596. Their planar structures and partial stereochemistries were determined based on the spectroscopic analysis, MMFF conformational search, and ECD calculations. Umezawamides are the first secondary metabolites isolated from the genus Umezawaea and they exhibited cytotoxicities to P388 murine leukemia cells. Furthermore, umezawamide A (1) showed growth inhibitory activity against Candida albicans.


Subject(s)
Actinomycetales/chemistry , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/isolation & purification , Lactams, Macrocyclic/isolation & purification , Lactams, Macrocyclic/pharmacology , Mycolic Acids/metabolism , Polycyclic Compounds/isolation & purification , Polycyclic Compounds/pharmacology , Animals , Anti-Bacterial Agents/pharmacology , Antibiotics, Antineoplastic/chemistry , Antibiotics, Antineoplastic/isolation & purification , Antibiotics, Antineoplastic/pharmacology , Antifungal Agents/chemistry , Antifungal Agents/isolation & purification , Antifungal Agents/pharmacology , Bacteria/drug effects , Candida albicans/drug effects , Cell Line, Tumor , Humans , Leukemia P388/drug therapy , Mice , Microbial Sensitivity Tests , Molecular Conformation
11.
Bull Exp Biol Med ; 163(3): 385-388, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28744633

ABSTRACT

We studied the effectiveness of cyclic hydroxamic acid CHA-5 against drug-resistant and multidrug-resistant murine P388 leukemia strains. More than 60% mice receiving transplantation of rubomycin-resistant leukemia P388 strain survived after CHA-5 monotherapy; combined therapy with CHA-5 and cisplatin was also highly effective. Vincristine-resistant tumor was highly sensitive to combined treatment with CHA-5 and cyclophosphamide. It should be emphasized that standard antitumor agents were used in very low doses in combination therapy and CHA-5 significantly potentiated their effect.


Subject(s)
Antineoplastic Agents/pharmacology , Cisplatin/pharmacology , Cyclophosphamide/pharmacology , Drug Resistance, Neoplasm/drug effects , Hydroxamic Acids/pharmacology , Leukemia P388/drug therapy , Animals , Antineoplastic Agents/chemical synthesis , Daunorubicin/pharmacology , Drug Administration Schedule , Drug Combinations , Drug Synergism , Hydroxamic Acids/chemical synthesis , Leukemia P388/mortality , Leukemia P388/pathology , Mice , Survival Analysis , Vincristine/pharmacology
12.
Chemistry ; 23(40): 9535-9545, 2017 Jul 18.
Article in English | MEDLINE | ID: mdl-28488778

ABSTRACT

The enantioselective total syntheses of lepadiformine marine alkaloids, azatricyclic natural products isolated from marine tunicates, were completed. These alkaloids have a unique chemical structure characterized by the trans-1-azadecalin (AB ring system) fused with the spirocyclic ring (AC ring system). Here we found that a cycloisomerization reaction from functionalized linear substrates to a 1-azaspiro[4.5]decane framework corresponding to the AC ring in lepadiformines is promoted by a catalytic amount of mercury(II) triflate (Hg(OTf)2 ). The total syntheses of (-)-lepadiformines A and B were achieved in 28 % and 21 % overall yields, respectively, through the novel cycloisomerization reaction. The syntheses of (+)- and (-)-lepadiformine C hydrochloride salts also enabled us to determine the absolute configuration of natural lepadiformine C. It has been found that a phenomenon of enantiodivergence occurs in lepadiformine alkaloids from a single species of marine tunicate, Clavelina moluccensis. The cytotoxic activities of synthesized lepadiformine hydrochloride salts and their synthetic intermediates were evaluated.


Subject(s)
Alkaloids/chemical synthesis , Antineoplastic Agents/chemical synthesis , Urochordata/chemistry , Alkaloids/pharmacology , Animals , Antineoplastic Agents/pharmacology , Aquatic Organisms , Catalysis , Cell Proliferation , Cell Survival , HT29 Cells , HeLa Cells , Humans , Leukemia P388 , Magnetic Resonance Spectroscopy , Mass Spectrometry/methods , Molecular Structure , Stereoisomerism
13.
Pharm Biol ; 55(1): 1638-1645, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28427292

ABSTRACT

CONTEXT: Sechium edule (Jacq.) Sw. (Cucurbitaceae) is used in ethnomedicine, but the diversity of the varietal groups of this species has not often been considered. This is important because we previously reported that different variety of species exhibit different activities across different tumor cell lines. OBJECTIVE: This study investigates the chemical composition and biological activities of extracts obtained from S. edule var. nigrum spinosum. MATERIALS AND METHODS: The leukemia P388 cell line and mononuclear bone marrow cells (MNCBMs) were treated with the extract at a concentration ranging from 40 to 2370 µg/mL for cytotoxicity and viability assays. CD-1 mice were treated with 8-5000 mg/kg extract and monitored every hour for the first 24 h and subsequently for seven days for signs of toxicity (LD50). In addition, the chromatographic profile of the extract was determined by HPLC. RESULTS: The extract inhibits the proliferation of both P388 cells and MNCBMs, with IC50 values of 927 and 1911 µg/mL, respectively, but reduced the viability and induced the apoptosis of only leukemia cells. The LD50 was higher than 5000 mg/kg, and this concentration did not alter the blood chemistry or cell count but doubled the mitotic index in the bone marrow. The HPLC showed the presence of cucurbitacins, phloridzin, naringenin, phloretin, apigenin, and gallic, chlorogenic, vanillic, p-hydroxybenzoic, caffeic, and p-coumaric acids. DISCUSSION AND CONCLUSION: Sechium edule var. nigrum spinosum contains bioactive compounds that explain the antiproliferative and nutraceutical activities, and its lack of physiological side effects constitutes an added value to a widely consumed vegetable.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Cucurbitaceae/chemistry , Leukemia P388/drug therapy , Plant Extracts/pharmacology , Animals , Antineoplastic Agents, Phytogenic/administration & dosage , Antineoplastic Agents, Phytogenic/toxicity , Apoptosis/drug effects , Bone Marrow Cells/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Survival/drug effects , Chromatography, High Pressure Liquid/methods , Dose-Response Relationship, Drug , Female , Fruit , Inhibitory Concentration 50 , Lethal Dose 50 , Leukemia P388/pathology , Male , Methanol/chemistry , Mice , Plant Extracts/administration & dosage , Plant Extracts/toxicity
14.
J Nat Prod ; 80(4): 1205-1209, 2017 04 28.
Article in English | MEDLINE | ID: mdl-28290701

ABSTRACT

A novel pyridinium with three indole moieties, tricepyridinium, was obtained from the culture of an Escherichia coli clone incorporating metagenomic libraries from the marine sponge Discodermia calyx. For the important structural elements of tricepyridinium to be investigated for antibacterial activity, tricepyridinium and its analogues were chemically synthesized. Tricepyridinium had antimicrobial activity, but not against E. coli, and cytotoxicity against P388 cells. Additional bioassays with its synthetic analogues revealed that the intriguing combination of the indole moieties, most likely derived from three tryptamines, as well as the pyridinium moiety were chiefly responsible for its potent biological activities.


Subject(s)
Anti-Bacterial Agents/isolation & purification , Anti-Infective Agents/isolation & purification , Indoles/chemistry , Porifera/chemistry , Pyridinium Compounds/isolation & purification , Animals , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Anti-Infective Agents/chemistry , Anti-Infective Agents/pharmacology , Escherichia coli/chemistry , Escherichia coli/drug effects , Leukemia P388 , Microbial Sensitivity Tests , Molecular Structure , Nuclear Magnetic Resonance, Biomolecular , Pyridinium Compounds/chemistry , Structure-Activity Relationship
15.
J Asian Nat Prod Res ; 19(2): 194-200, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27329305

ABSTRACT

A new lanostane-type triterpenoid, 3ß-hydroxy-25-ethyl-lanost-9(11),24(24')-diene (1), along with 3ß-hydroxy-lanost-7-ene (2) and ß-sitosterol-3-O-acetate (3) was isolated from the stem bark of C. cumingianus. The chemical structure of the new compound was elucidated on the basis of spectroscopic data. All of the compounds were evaluated for their cytotoxic effects against P-388 murine leukemia cells. Compounds 1-3 showed cytotoxicity against P-388 murine leukemia cells with IC50 values of 28.8 ± 0.10, 4.29 ± 0.03, and 100.18 ± 0.16 µg/ml, respectively.


Subject(s)
Antineoplastic Agents, Phytogenic/isolation & purification , Antineoplastic Agents, Phytogenic/pharmacology , Meliaceae/chemistry , Plant Bark/chemistry , Sitosterols/isolation & purification , Triterpenes/isolation & purification , Triterpenes/pharmacology , Animals , Antineoplastic Agents, Phytogenic/chemistry , Drug Screening Assays, Antitumor , Humans , Inhibitory Concentration 50 , Lanosterol/analogs & derivatives , Leukemia P388 , Mice , Molecular Structure , Sitosterols/chemistry , Sitosterols/pharmacology , Triterpenes/chemistry
16.
J Nat Prod ; 79(9): 2418-22, 2016 09 23.
Article in English | MEDLINE | ID: mdl-27551908

ABSTRACT

New N-sulfoureidylated lipopeptides, sulfolipodiscamides A-C (1-3), were isolated by gel filtration chromatography of the n-butanol fraction of the marine sponge Discodermia kiiensis. By extensive NMR analyses and high-resolution mass spectrometry, the structures of 1-3 were elucidated as having an unprecedented N-sulfoureidyl group on the d-citrulline residue, a distinct feature that was not found in the structurally related lipodiscamides A-C (4-6), derived from the ether fraction of the same sponge. Furthermore, the absolute configurations of 1-3 were confirmed by comparisons of the HPLC retention times of the hydrolytic products and the corresponding authentic lipodiscamides. Interestingly, sulfolipodiscamide A displayed a 2.3-fold increase in cytotoxicity against murine leukemia (P388) cells, compared to the unconjugated parent compound.


Subject(s)
Lipopeptides/isolation & purification , Porifera/chemistry , Animals , Drug Screening Assays, Antitumor , Humans , Leukemia P388 , Lipopeptides/chemistry , Lipopeptides/pharmacology , Marine Biology , Mice , Molecular Structure , Nuclear Magnetic Resonance, Biomolecular
17.
Steroids ; 115: 1-8, 2016 11.
Article in English | MEDLINE | ID: mdl-27473822

ABSTRACT

Alkylating agents are still nowadays one of the most important classes of cytotoxic drugs, which display a wide range of therapeutic use for the treatment of various cancers. We have synthesized and tested four hybrid homo-azasteroidal alkylating esters for antileukemic activity against five sensitive to alkylating agents human leukemia cell lines in vitro and against P388 murine leukemia in vivo. Comparatively, melphalan and 3-(4-(bis(2-chloroethyl)amino)phenoxy)propanoic acid (POPAM) were also examined. All the homo-aza-steroidal alkylators showed relatively lower acute toxicity, very promising and antileukemic activity both in vitro and in vivo.


Subject(s)
Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/therapeutic use , Lactams/chemical synthesis , Lactams/therapeutic use , Leukemia P388/drug therapy , Steroids/chemical synthesis , Steroids/therapeutic use , Aniline Mustard/chemistry , Animals , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Cell Line, Tumor , Female , Humans , Jurkat Cells , K562 Cells , Lactams/chemistry , Lactams/pharmacology , Male , Mechlorethamine/chemistry , Mice, Inbred BALB C , Steroids/chemistry , Steroids/pharmacology , Structure-Activity Relationship
18.
J Nat Prod ; 79(6): 1598-603, 2016 06 24.
Article in English | MEDLINE | ID: mdl-27214528

ABSTRACT

The Zimbabwean medicinal plant Monadenium lugardae was evaluated as a potential source of new anticancer constituents. Four new tetracyclic triterpene (1-4) were isolated, accompanied by four previously known triterpenes (5-8). Against a panel of human tumor cell lines, lugardstatins 1 (1) and 2 (2) had good cancer cell growth inhibitory activity. All of the triterpene structures (1-8) were established by 1D and 2D NMR spectrometric and HR mass spectrometric analysis.


Subject(s)
Antineoplastic Agents, Phytogenic/isolation & purification , Euphorbia/chemistry , Plants, Medicinal/chemistry , Triterpenes/isolation & purification , Triterpenes/pharmacology , Animals , Antineoplastic Agents, Phytogenic/chemistry , Antineoplastic Agents, Phytogenic/pharmacology , Drug Screening Assays, Antitumor , Humans , Leukemia P388 , Molecular Structure , Nuclear Magnetic Resonance, Biomolecular , Triterpenes/chemistry , Zimbabwe
19.
J Nat Prod ; 78(12): 3011-7, 2015 Dec 24.
Article in English | MEDLINE | ID: mdl-26624939

ABSTRACT

A terrestrial bacterium, Streptomyces sp. NZ-6, produced niizalactams A-C (1-3), unprecedented di- and tricyclic macrolactams, by coculturing with the mycolic acid-containing bacterium Tsukamurella pulmonis TP-B0596. Their complete structures, including absolute configurations, were elucidated on the basis of spectroscopic data and chemical derivatization. Their unique skeletons are proposed to be biosynthesized from a common 26-membered macrolactam intermediate by SN2 cyclization or an intramolecular Diels-Alder reaction.


Subject(s)
Lactams, Macrocyclic/isolation & purification , Streptomyces/chemistry , Animals , Bacillus subtilis/drug effects , Candida albicans/drug effects , Drug Screening Assays, Antitumor , Lactams, Macrocyclic/chemistry , Lactams, Macrocyclic/pharmacology , Leukemia P388 , Microbial Sensitivity Tests , Molecular Structure , Mycolic Acids/chemistry , Nuclear Magnetic Resonance, Biomolecular , Saccharomyces cerevisiae/drug effects
20.
Phytomedicine ; 22(13): 1186-94, 2015 Dec 01.
Article in English | MEDLINE | ID: mdl-26598918

ABSTRACT

BACKGROUND: High consumption of flavonoids has been associated with a decrease risk of cancer. Alfalfa (Medicago sativa) leaves have been widely used in traditional medicine and is currently used as a dietary supplement because of their high nutrient content. We previously reported the cytotoxic activity of alfalfa leaf extracts against several sensitive and multidrug resistant tumor cell lines. HYPOTHESIS/PURPOSE: We aimed to determine whether medicarpin and millepurpan, two isoflavonoids isolated from alfalfa leaves, may have pro-apoptotic effects against drug-sensitive (P388) and multidrug resistant P388 leukemia cells (P388/DOX). STUDY DESIGN/METHODS: Cells were incubated with medicarpin or millepurpan for the appropriate time. Cell viability was assessed by the MTT assay. DNA fragmentation was analyzed by agarose gel electrophoresis. Cell cycle analysis was realized by flow cytometry technics. Caspases 3 and 9 activities were measured using Promega caspACE assay kits. Proteins and genes expression were visualized respectively by western-blot using specific antibodies and RT-PCR assay. RESULTS: P-glycoprotein-expressing P388/DOX cells did not show resistance to medicarpin (IC50 ≈ 90 µM for P388 and P388/DOX cells) and millepurpan (IC50 = 54 µM and 69 µM for P388 and P388/DOX cells, respectively). Treatment with medicarpin or millepurpan triggered apoptosis in sensitive as well as multidrug resistant P388 cells. These effects were mediated through the mitochondrial pathway by modifying the balance pro/anti-apoptotic proteins. While 3 µM doxorubicin alone could not induce cell death in P388/DOX cells, concomitant treatment with doxorubicin and subtoxic concentration of medicarpin or millepurpan restored the pro-apoptotic cascade. Each compound increased sensitivity of P388/DOX cells to doxorubicin whereas they had no effect in sensitive P388 cells. Vinblastine cytotoxicity was also enhanced in P388/DOX cells (IC50 = 210 nM to 23 and 25 nM with medicarpin and millepurpan, respectively). This improved sensitivity was mediated by an increased uptake of doxorubicin in P388/DOX cells expressing P-gp. P-gp expression was not altered by exposure to medicarpin and millepurpan. CONCLUSION: These data indicate that medicarpin and millepurpan possess pro-apoptotic properties and potentiate the cytotoxicity of chemotherapy drugs in multidrug resistant P388 leukemia cells by modulating P-gp-mediated efflux of drugs. These flavonoids may be used as chemopreventive agents or as sensitizer to enhance cytotoxicity of chemotherapy drugs in multidrug resistant cancer cells.


Subject(s)
Apoptosis/drug effects , Drug Resistance, Multiple/drug effects , Drug Resistance, Neoplasm/drug effects , Flavonoids/pharmacology , Leukemia P388/metabolism , Medicago sativa/chemistry , Pterocarpans/pharmacology , ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism , Animals , Caspases/metabolism , Cell Line, Tumor/drug effects , Doxorubicin , Mice , Molecular Structure , Plant Leaves/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...